Authors
Shevchenko Yu.L., Borshchev G.G., Baikov V.Yu.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Despite the development of medical and surgical treatment of patients with coronary artery disease, standard methods are not applicable in determining the tactics of managing a number of patients.
A unique clinical case of a 56-year-old female patient who, 15 years before hospitalization, underwent coronary artery bypass grafting of atherosclerotic coronary arteries from the sternotomy approach is presented. After 10 years from the operation, she began to worry about relapses of angina pectoris. Control examination revealed occlusion of the shunt to the anterior interventricular artery, which caused ischemia of the anterior and lateral walls of the left ventricle according to the results of scintigraphy.
In order to minimize the operative access and in connection with the high risk of performing sternotomy, as well as due to the diffuse nature of the coronary bed lesion, a minimally invasive surgical approach from the left-sided thoracotomy was chosen, while, along with the diagonal branch bypass, the technique of stimulating extracardiac angiogenesis (YurLeon) was performed.
The postoperative period and follow-up for 1 year — with significant positive dynamics.
Gentle access, along with the use of the YurLeon technique, made it possible to achieve a good result in a patient with diffuse atherosclerosis preceding CABG, moreover, reducing the degree of surgical aggression.
Keywords: repeated coronary artery bypass grafting, neoangiogenesis, minithoracotomy, sternotomy.
References
1. Bockeriya LA. Minimally invasive heart surgery. M.: Medicine, 1998. 92 p. (In Russ).
2. Shevchenko YuL, Simonenko VB, Borshchev GG. Extracardial revascularization of the myocardium in diffuse lesions of the coronary bed, as a component of complex treatment of patients with coronary heart disease. Klinicheskaya medicina. 2018; 96(11): 10-18. (In Russ).
3. Hubulava GG, Payvin AA, Volkov AM, Odenisyuk DO, Yurchetso DL, Lyubimov AI. Features of surgical treatment of recurrent myocardial ischemia in patients after coronary artery bypass grafting. Bulletin of the North-West State Medical University. 2009; 1(3): 21-28. (In Russ).
4. Fuchs S, Dib N, Cohen BM, Okubagzi P, Diethrich EB, Campbell А, Macko J. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter- based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery diseasе. Catheter Cardiovasc Interv. 2006; 68(3): 372-8.
5. Shevchenko YuL, Pinaev GP, Matveev SA, Semenova VG, Erokhina IL, Makhnev DA. The first experience of implantation of human embryonic cardiomyocytes (EC) in the complex treatment of patients with coronary heart disease. 4th All-Russian Congress of Cardiovascular Surgeons. 1998. (In Russ).
6. Shevchenko YuL, Popov LV, Batrashov VA, et al. Difficulties in choosing the volume of revascularization in the treatment of coronary heart disease in a high-risk patient. Vestnik Nacional`nogo mediko-xirurgicheskogo Centra im. N.I. Pirogova. 2015; 10(4): 134-136. (In Russ).
7. Shevchenko YuL, Viller AG. Extracardial revascularization in patients with coronary heart disease after coronary bypass surgery is an existing factor of myocardial blood supply. Vestnik Nacional’nogo mediko-hirurgicheskogo Centra im. N.I. Pirogova. 2007; 2(2): 9-14. (In Russ).
8. Borshchev GG. Extravascular myocardial revascularization in complex treatment of patients with coronary artery disease: historical background and current realities. Medicinskij vestnik Yuga Rossii. 2015; 2: 4-8. (In Russ). doi: 10.21886/2219-8075- 2015-2-4-8.
